120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Issue 1 (April 2015) - Schuler, E.; Schemenau, J.; Giagounidis, A.; Haase, D.; Büsche, G.; Platzbecker, U.; Nolte, F.; Götze, K.; Schlenk, R.F.; Ganser, A.; Letsch, A.; Lübbert, M.; et al.